Astrana Health (ASTH) Stock Price, News & Analysis

Company Overview

Astrana Health, Inc. is a healthcare enablement company that helps physicians and other healthcare providers deliver coordinated, value-based care. The company works with medical groups, independent physician associations and healthcare organizations to manage patient populations, improve clinical outcomes and coordinate services across primary, specialty and post-acute care settings.

Astrana Health provides care-management programs, population-health analytics, technology solutions and administrative support designed to help providers manage risk-based reimbursement arrangements. Its services support Medicare Advantage, accountable care and other value-based care models, with an emphasis on preventive care, chronic-condition management, utilization management and reducing avoidable hospital and emergency-room use.

The company was founded in 1994 and was formerly known as Apollo Medical Holdings, Inc. It adopted the Astrana Health name in 2023 as part of a broader effort to present its healthcare enablement platform under a unified brand. The company primarily serves healthcare providers and patients in the United States, with operations and affiliated networks concentrated in markets including California, Nevada and Texas. Astrana Health is led by Chief Executive Officer Brandon Sim.

Key Stats

• Today's Range: $36.65 to $37.66
• 50-Day Range: $33.55 to $40.81
• 52-Week Range: $18.08 to $51.60
• Volume: 664,495 shs
• Average Volume: 420,546 shs
• Market Capitalization: $2.07 billion
• P/E Ratio: 45.29
• Dividend Yield: N/A
• Price Target: $49.88
• Consensus Rating: Moderate Buy

Astrana Health Stock Analysis - MarketRank™

Astrana Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 238th out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Astrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

Astrana Health has a consensus price target of $49.88, representing about 34.3% upside from its current price of $37.14.

Amount of Analyst Coverage

Astrana Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 41.91%

Earnings Growth

Earnings for Astrana Health are expected to grow by 41.91% in the coming year, from $1.36 to $1.93 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Astrana Health is 45.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 41.60.

Price to Earnings Ratio vs. Sector

The P/E ratio of Astrana Health is 45.29, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 202.31.

Price to Book Value per Share Ratio

Astrana Health has a P/B Ratio of 2.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.37% of the float of Astrana Health has been sold short.

Short Interest Ratio / Days to Cover

Astrana Health has a short interest ratio ("days to cover") of 11.71, which indicates bearish sentiment.

Change versus previous month

Short interest in Astrana Health has recently decreased by 0.27%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Astrana Health does not currently pay a dividend.

Dividend Growth

Astrana Health does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Astrana Health this week, compared to 3 articles on an average week.

Company Ownership

• Score: 1.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Astrana Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.30% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/07/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:ASTH
• Previous Symbol: NASDAQ:ASTH
• CIK: 1083446
• Web: www.astranahealth.com
• Phone: 626-282-0288
• Fax: 818-839-5190
• Employees: 3,000
• Year Founded: 1985

Price Target and Rating

• Average Price Target for Astrana Health: $49.88
• High Price Target: $65.00
• Low Price Target: $37.00
• Potential Upside/Downside: +34.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.82
• Trailing P/E Ratio: 45.29
• Forward P/E Ratio: 27.31
• P/E Growth: N/A
• Net Income: $22.49 million
• Net Margins: 1.05%
• Pretax Margin: 1.56%
• Return on Equity: 10.30%
• Return on Assets: 3.67%

Debt

• Debt-to-Equity Ratio: 1.05
• Current Ratio: 1.23
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: $3.18 billion
• Price / Sales: 0.65
• Cash Flow: $2.82 per share
• Price / Cash Flow: 13.15
• Book Value: $14.09 per share
• Price / Book: 2.64

Miscellaneous

• Outstanding Shares: 55,740,000
• Free Float: 44,422,000
• Market Cap: $2.07 billion
• Optionable: Optionable
• Beta: 1.03